Apimeds Pharmaceuticals US, Inc (APUS)

AMEX·Healthcare·Drug Manufacturers - Specialty & Generic

$1.29

+3.20%

Mkt Cap $16.35M

No analyst coverage available

We don't have analyst ratings or price target data for Apimeds Pharmaceuticals US, Inc yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.